Kolen Co Ltd <078650.KQ> :Says it receives patent on Sept. 21, for photographic lens optical system.
Kolen Co Ltd <078650.KQ> :Says it receives patent on Sept. 21, for voice Coil Motor Auto focus module and Camera adopting the module.
C. R. Bard, Inc : Approves 6 Primary efficacy end point in clinical trial is a composite of limb salvage and primary patency at 6 months . Month primary end point for the Lutonix® below-the-knee drug coated balloon .Primary safety end point in clinical trial is freedom from major adverse limb event or postoperative death at 30 days.
Neogen Corp :Received approval from AOAC research institute for its accupoint advanced ATP sanitation monitoring system.
QT Vascular Ltd : Media release - FDA grants conditional IDE approval for chocolate touch clinical trials . Approval allows co to begin enrolling patients in the pivotal study of its novel chocolate touchtm drug-coated balloon .
Mimedx Group Inc : Mimedx says continues to believe that its marketing of its products as section 361 hct/ps is consistent with applicable statutes and regulations . Mimedx urges FDA to reconsider draft guidances during hearing . Says urged FDA to reconsider its draft guidances on "minimal manipulation" and homologous use of human cells .Says "draft guidances cannot lawfully be adopted in their current form".
Episurf Medical AB : Obtains its first granted patent in Australia .Patent covers a surgical drilling guide with a functionality for depth adjustments.
Medovex Corporation : Medovex Corporation enters into international distribution agreement with M.fast Technologies LTD . Agreement covers distribution of its DenerveX system throughout Israel .DenerveX is not yet ce marked or FDA cleared and is not yet commercially available.
Medtronic Plc : Medtronic Plc says receives FDA approval of first drug coated balloon for treatment of in-stent restenosis .Medtronic plc says fda approval was based on isr data from in.pact global study compared to a standard percutaneous balloon angioplasty control.